![Erik Engebretsen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Mr. Erik Engebretsen is Chairman at PhotoCure ASA, Chairman at Mallin Venture AS, and a Managing Director at Gezina AS.
He is on the Board of Directors at Farma Holding AS.
Anciens postes connus de Erik Engebretsen
| Sociétés | Poste | Fin |
|---|---|---|
| PHOTOCURE ASA | Président | 27/04/2011 |
Mallin Venture AS
 Mallin Venture AS Investment ManagersFinance MV's venture capital investment strategy focuses on firms displaying high-growth potential in international markets. Their investment objective is to create long-term capital growth through an investment philosophy which promotes concepts of corporate sustainability. They look for investments where they can add value based on their core business development competencies. They target investment sectors within clean technology. MV also evaluates other investment criteria such as established firms with sector-experienced managers in key positions, products that have clear utility, viable business model, documented experience on the international market, firms facing a development phase that will improve the company's market position and value, competitively sustainable activity or product, and sound company ethics. MV's investment level ranges from NOK 4 million to 15 million. They take direct equity or provide convertible loans. They take minority positions from 10% to 49%. As active investment partners, they take Board seats on their portfolio firms. Their investment time frame generally ranges from three to seven years. Their exit strategy is influenced by the level of value creation. They exit though trade sales and buyouts. | Président | 31/03/2010 |
Sanivo Pharma AS
 Sanivo Pharma AS Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products and services | Directeur/Membre du Conseil | - |
Gezina AS
 Gezina AS Financial ConglomeratesFinance Engages in shipping and investment activities | Directeur Général | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
16
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Photocure ASA
 Photocure ASA Medical SpecialtiesHealth Technology Develops and sells pharmaceuticals and medical devices | Health Technology |
Gezina AS
Gezina AS Financial ConglomeratesFinance Engages in shipping and investment activities | Finance |
Mallin Venture AS
Mallin Venture AS Investment ManagersFinance MV's venture capital investment strategy focuses on firms displaying high-growth potential in international markets. Their investment objective is to create long-term capital growth through an investment philosophy which promotes concepts of corporate sustainability. They look for investments where they can add value based on their core business development competencies. They target investment sectors within clean technology. MV also evaluates other investment criteria such as established firms with sector-experienced managers in key positions, products that have clear utility, viable business model, documented experience on the international market, firms facing a development phase that will improve the company's market position and value, competitively sustainable activity or product, and sound company ethics. MV's investment level ranges from NOK 4 million to 15 million. They take direct equity or provide convertible loans. They take minority positions from 10% to 49%. As active investment partners, they take Board seats on their portfolio firms. Their investment time frame generally ranges from three to seven years. Their exit strategy is influenced by the level of value creation. They exit though trade sales and buyouts. | Finance |
Sanivo Pharma AS
Sanivo Pharma AS Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products and services | Health Technology |
